Federal Appeals Court Reinstates In-Person Requirement for Mifepristone
Similar Articles
Appeals Court Blocks Mailing of Abortion Pill Mifepristone, Reinstates In-Person Requirement
Supreme Court Extends Telemedicine Access to Abortion Pill Mifepristone Through Thursday
Supreme Court Temporarily Blocks Nationwide Ban on Telemedicine Abortion Access
Supreme Court Maintains Telehealth Access to Abortion Pill Mifepristone
Supreme Court Temporarily Restores Mail-Order Access to Abortion Pill Mifepristone
A federal appeals court panel has ordered the FDA to return to earlier rules requiring in-person prescribing for the abortion medication mifepristone, applying the change immediately nationwide. The makers of mifepristone have appealed to the Supreme Court to restore the relaxed Biden-era rules, which allowed telemedicine prescribing and pharmacy pickup. The standard two-drug medication regimen remains available for in-person patients in states where abortion is legal.
Facts First
- A federal appeals court order requires in-person prescribing for mifepristone, reversing Biden-era FDA rules.
- The change applies immediately nationwide, affecting telemedicine and pharmacy access.
- The drug's makers have appealed to the Supreme Court seeking a return to the relaxed rules.
- The two-drug regimen remains available for in-person patients in states where abortion is legal.
- Telemedicine abortions may continue in legal states using only the second drug, misoprostol.
What Happened
A federal appeals court panel issued an order requiring the Food and Drug Administration (FDA) to return to earlier prescribing rules for the medication mifepristone. This change applies immediately across the country. For more than 20 years, mifepristone has been used with misoprostol for most medication abortions in the U.S. Under the now-reversed Biden-era FDA rules, mifepristone could be prescribed over the phone or online and mailed or picked up at pharmacies for pregnancies up to 10 weeks. The makers of mifepristone have appealed this order to the Supreme Court.
Why this Matters to You
If you are seeking a medication abortion, this ruling may restrict your access to the most common two-drug regimen unless you can visit a provider in person. In states where abortion is legal, you can still obtain the regimen through an in-person visit. For telemedicine services in those states, providers may now offer abortions using only misoprostol, which is widely available in pharmacies due to its other medical uses. The misoprostol-only regimen is effective but typically takes longer to complete than the two-drug combination. You should seek medical help for heavy or prolonged bleeding or a fever persisting more than 24 hours after taking misoprostol.
What's Next
The Supreme Court may now consider the appeal from the makers of mifepristone, which could lead to a reinstatement of the telemedicine rules. In the meantime, organizations like Aid Access, based in the Netherlands, may continue mailing mifepristone and misoprostol to patients. Resources like Abortionfinder.org and the Miscarriage and Abortion Hotline are available to help navigate services and legal information.